Description
Product Description
Fosfomycin Sodium (CAS 26016-99-9) is a broad-spectrum phosphonic acid antibiotic widely employed in preclinical microbiology and pharmacology research. As a small-molecule antibacterial agent, it irreversibly inhibits the enzyme MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), blocking the first committed step of bacterial peptidoglycan biosynthesis. This unique mechanism makes it a valuable tool for mechanistic studies of bacterial cell wall formation, antibiotic synergy, and resistance pathways.
The Fosfomycin Sodium lyophilized powder form allows for precise preparation of solutions at defined concentrations, enhancing reproducibility in in vitro assays, time-kill studies, and in vivo preclinical models. Researchers commonly use Fosfomycin Sodium to study the effects of cell wall inhibition, bacterial growth suppression, and combination therapy with beta-lactams, aminoglycosides, or other antibiotics.
Mechanistically, Fosfomycin enters bacterial cells via glycerophosphate and hexose-6-phosphate transporters. Once inside, it covalently binds to MurA, preventing the conversion of UDP-N-acetylglucosamine to UDP-N-acetylmuramic acid. This leads to cell wall synthesis arrest, bacterial growth inhibition, and ultimately bactericidal activity. The compound is effective against both Gram-positive and Gram-negative bacteria, making it versatile for broad preclinical studies.
Fosfomycin Sodium is also used to evaluate bacterial resistance mechanisms, such as transporter mutations and fosfomycin-modifying enzymes. Its high-purity lyophilized form ensures stability, accuracy in experimental dosing, and compatibility with combination studies, pharmacokinetic profiling, and microbiological assays.

Product Specifications
| Parameter | Specification / Data |
|---|---|
| Chemical Name / Synonyms | Fosfomycin Sodium; Monosodium phosphonic acid derivative; C3H6NaO4P |
| CAS Number | 26016-99-9 |
| Molecular Formula | C3H5NaO4P |
| Molecular Weight | 138.06 g/mol |
| Purity / Assay | ≥99% |
| Appearance | White lyophilized powder |
| Dosage Form | Lyophilized powder for research (Fosfomycin Sodium) |
| Solubility | Highly soluble in water; stable in aqueous solution |
| Storage Temperature | 2–8 °C; protect from moisture |
| Stability | Stable as lyophilized powder; reconstituted solutions should be used immediately or stored frozen |
| Mechanistic Target | MurA enzyme, bacterial cell wall synthesis, peptidoglycan biosynthesis |
| Structural Category | Phosphonic acid antibiotic, bactericidal agent |
| Applications | Antibacterial studies, cell wall synthesis inhibition, resistance mechanism evaluation, combination therapy research, pharmacokinetic studies, in vitro and in vivo microbiology assays |
| Analytical Methods | HPLC, MS, NMR verified; batch consistency confirmed |
| Regulatory Notes | For laboratory research use only |
| Origin | Factory chemical supplier, China; OEM & bulk production available |
| Additional Data | SMILES: C(CO)P(=O)(O)O.Na; CoA provided for each batch |
Mechanism of Action
Cell Wall Synthesis Inhibition
Fosfomycin Sodium targets the MurA enzyme, blocking the formation of UDP-N-acetylmuramic acid, an essential precursor for bacterial peptidoglycan. This inhibition prevents cell wall synthesis and leads to bacterial cell lysis.
Transport and Uptake
Enters bacteria via glycerophosphate and hexose-6-phosphate transporters
High uptake efficiency contributes to broad-spectrum activity
Bactericidal Activity
Arrests bacterial growth by inhibiting cell wall biosynthesis
Rapidly induces cell death in susceptible Gram-positive and Gram-negative species
Mechanistic studies include time-kill curves and bacteriolytic assessments
Resistance Mechanism Modeling
Investigates transporter mutations affecting Fosfomycin uptake
Evaluates bacterial FosA/FosB enzyme-mediated modifications
Enables combination therapy research to overcome resistance

Applications
Preclinical antibacterial studies
Mechanistic investigation of peptidoglycan synthesis inhibition
Resistance mechanism modeling
Combination therapy and synergy studies
In vitro and in vivo microbiology assays
Pharmacokinetic and pharmacodynamic research
High-throughput screening for antibacterial compounds
Bacterial cytotoxicity and growth inhibition research
Side Effects (Preclinical Observations)
Cellular Effects:
Inhibition of bacterial cell wall synthesis
Growth arrest and cell lysis
Laboratory Handling:
Use PPE when handling lyophilized powder
Avoid inhalation, ingestion, or skin contact
Handle in fume hood, dispose of as hazardous waste
Keywords
Fosfomycin Sodium, CAS 26016-99-9, lyophilized powder, MurA inhibitor, bacterial cell wall synthesis inhibitor, antibacterial research, cytotoxicity studies, combination therapy research, preclinical microbiology reagent, high-purity research chemical, laboratory antibiotic, OEM & bulk supply.
Shipping Guarantee
Fosfomycin Sodium lyophilized powder is packaged to protect from moisture and shipped via international express couriers with temperature monitoring where necessary. Packages are insured and tracked to ensure compound integrity.
Trade Assurance
≥99% purity verified by HPLC, MS, NMR
Batch consistency confirmed
Certificate of Analysis (CoA) included
OEM & bulk packaging available
Replacement or refund guaranteed for specification deviation
Payment Support
PayPal
Credit Cards (Visa, MasterCard, AmEx)
Bank Transfer (T/T)
USDT / BTC / ETH
Corporate invoicing for bulk orders
Disclaimer
Fosfomycin Sodium is supplied for laboratory research only. Not for human or veterinary use. Researchers must adhere to institutional safety guidelines. Supplier assumes no liability for misuse.




Reviews
There are no reviews yet.